Gellycle

Develops Tetra-PEG hydrogel-based pharmaceuticals and medical devices that form gels inside the body to address bleeding, tendon adhesion, cataract surgery complications, ligament rupture, varicose veins, vascular embolization, and tissue regeneration, then degrade and disappear leaving healed tissue. Sells to business customers in healthcare and life sciences seeking joint research and co-development of gel-based medical products. Delivers through implantable and injectable hydrogel hardware and collaborative research and development partnerships.

Key features

• Local hemostatic material gelling on blood contact
• Adhesion prevention material for tendon healing
• Ophthalmic surgical aid for cataract surgery
• High-strength gel thread for artificial ligament
• Hydrogel device for varicose veins treatment
• Novel vascular embolization material
• Scaffold material for regenerative medicine
• Drug delivery system gel for local release
• Hydro-release injection material using viscoelastic liquid
• Iontophoresis transdermal drug absorption
• Tissue protection and wound dressing material
• Cell and microbe culture medium alternative